Cargando…

Anticancer drug development /

Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Baguley, Bruce C., Kerr, David J.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: San Diego : Academic Press, �2002.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • A brief history of cancer chemotherapy
  • Novel targets in the cell cycle and cell cycle checkpoints
  • Growth factor and signal transduction targets for cancer therapy
  • Cell death pathways as targets for anticancer drugs
  • Drug resistance pathways as targets
  • Role of matrix metalloproteinases and plasminogen activators in cancer invasion and metastasis: therapeutic strategies
  • Tumor vasculature as a target
  • Gene-directed enzyme prodrug therapy
  • Tumor antigens as targets for anticancer drug development
  • Structure-based drug design and its contributions to cancer chemotherapy
  • The contribution of synthetic organic chemistry to anticancer drug development
  • Biosynthetic products for anticancer drug design and treatment: the bryostatins
  • DNA-encoded peptide libraries and drug discovery
  • Mechanism-based high-throughput screening for novel anticancer drug discovery
  • Tumor cell cultures in drug development
  • Screening using animal systems
  • Relevance of preclinical pharmacology and toxicology to Phase I trial extrapolation techniques: relevance of animal toxicity
  • Clinical trial design: incorporation of pharmacokinetic, pharmacodynamic, and pharmacogenetic principle
  • Tumor imaging applications in the testing of new drugs
  • Mechanistic approaches to Phase I clinical trials.